Clinical Trial Update: Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 safety and efficacy trial of DE-110 ophthalmic suspension for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• DE-110 Ophthalmic Suspension (DE-110)

Snippet

Sponsor: Santen Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED